TY - JOUR
T1 - Melanoma
T2 - Cutaneous, Version 2.2021 Featured Updates to the NCCN Guidelines
AU - Swetter, Susan M.
AU - Thompson, John A.
AU - Albertini, Mark R.
AU - Barker, Christopher A.
AU - Baumgartner, Joel
AU - Boland, Genevieve
AU - Chmielowski, Bartosz
AU - DiMaio, Dominick
AU - Durham, Alison
AU - Fields, Ryan C.
AU - Fleming, Martin D.
AU - Galan, Anjela
AU - Gastman, Brian
AU - Grossmann, Kenneth
AU - Guild, Samantha
AU - Holder, Ashley
AU - Johnson, Douglas
AU - Joseph, Richard W.
AU - Karakousis, Giorgos
AU - Kendra, Kari
AU - Lange, Julie R.
AU - Lanning, Ryan
AU - Margolin, Kim
AU - Olszanski, Anthony J.
AU - Ott, Patrick A.
AU - Ross, Merrick I.
AU - Salama, April K.
AU - Sharma, Rohit
AU - Skitzki, Joseph
AU - Sosman, Jeffrey
AU - Wuthrick, Evan
AU - McMillian, Nicole R.
AU - Engh, Anita M.
N1 - Publisher Copyright:
© 2021 Harborside Press. All rights reserved.
PY - 2021/4
Y1 - 2021/4
N2 - Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.
AB - Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.
UR - http://www.scopus.com/inward/record.url?scp=85104356321&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2021.0018
DO - 10.6004/jnccn.2021.0018
M3 - Review article
C2 - 33845460
AN - SCOPUS:85104356321
SN - 1540-1405
VL - 19
SP - 364
EP - 376
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 4
ER -